Article ID Journal Published Year Pages File Type
10956289 Molecular and Cellular Endocrinology 2012 8 Pages PDF
Abstract
► Dual inhibition of mTOR with MEK synergistically decreases cell proliferation by suppressing cell cycle in NET cells. ► The simultaneous treatment also inhibits cell migration by decreasing migration factors, MMP2 and MMP9. ► The combined therapy of mTOR and MEK inhibitors may be an effective treatment for NET patients.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cell Biology
Authors
, , , , , , ,